Exposure to intrauterine inflammation and late-onset sepsis in very preterm infants

Pediatr Res. 2022 Jan;91(1):230-234. doi: 10.1038/s41390-021-01455-0. Epub 2021 Mar 17.

Abstract

Background: Late-onset sepsis is an important cause of mortality and morbidity in preterm infants. As these infants rely mostly on their innate immune system to fight off infection, enhancing this immune system by appropriate stimuli may prevent late-onset sepsis. However, it remains unclear which stimuli can enhance the neonatal immune system. This study aims to investigate the influence of intrauterine inflammation on late-onset sepsis.

Methods: This is a retrospective cohort study in a Neonatal Intensive Care Unit in the Netherlands. Between 2005 and 2016, 1014 infants with ≤32 weeks gestational age and/or with a birth weight ≤1500 g were included. Intrauterine inflammation was subdivided into histological chorioamnionitis, fetal inflammatory response, and funisitis. Logistic and Cox regression analyses were performed to investigate the influence of intrauterine inflammation on late-onset sepsis.

Results: Thirty-six percent of the included infants developed late-onset sepsis; 24% of placentas showed intrauterine inflammation. Late-onset sepsis incidence did not differ between infants with or without exposure to intrauterine inflammation after adjustment for gestational age (histological chorioamnionitis aHR 0.928 [CI: 0.727-1.185], p = 0.551; fetal inflammatory response aHR 1.011 [CI: 0.793-1.288], p = 0.930); funisitis aHR 0.965 [CI: 0.738-1.263], p = 0.797).

Conclusions: Late-onset sepsis in very preterm infants seems not to be associated with intrauterine inflammation.

Impact: Intrauterine inflammation is not protective of developing late-onset sepsis in premature infants. A large cohort study on the effect of intrauterine inflammation on neonatal outcome. This study adds to existing knowledge on finding appropriate stimuli to enhance the immune system of premature infants to improve neonatal outcome.

MeSH terms

  • Female
  • Humans
  • Immunity, Innate
  • Infant, Extremely Premature*
  • Infant, Newborn
  • Inflammation / complications*
  • Inflammation / immunology
  • Neonatal Sepsis / complications*
  • Neonatal Sepsis / immunology
  • Retrospective Studies
  • Risk Factors
  • Uterine Diseases / complications*
  • Uterine Diseases / immunology